EP 3052487 A4 20170503 - STABILIZED EFINACONAZOLE COMPOSITIONS
Title (en)
STABILIZED EFINACONAZOLE COMPOSITIONS
Title (de)
STABILISIERTE EFINACONAZOLZUSAMMENSETZUNGEN
Title (fr)
COMPOSITIONS D'ÉFINACONAZOLE STABILISÉE
Publication
Application
Priority
- US 201361886569 P 20131003
- US 201461922867 P 20140101
- US 2014058911 W 20141002
Abstract (en)
[origin: US2015099785A1] The present invention provides compositions containing efinaconazole, butylated hydroxytoluene, a salt of ethylenediaminetetraacetic acid, and optional citric acid. The compositions exhibit stable color profiles and are useful in the treatment of fungal infections.
IPC 8 full level
C07D 405/00 (2006.01); A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 9/08 (2006.01); A61K 31/454 (2006.01); A61K 47/10 (2017.01); A61K 47/12 (2006.01); A61K 47/18 (2017.01)
CPC (source: EP KR US)
A61K 9/0014 (2013.01 - EP KR US); A61K 9/06 (2013.01 - EP KR US); A61K 9/08 (2013.01 - EP KR US); A61K 31/05 (2013.01 - KR); A61K 31/198 (2013.01 - KR); A61K 31/4196 (2013.01 - KR); A61K 31/454 (2013.01 - EP KR US); A61K 47/10 (2013.01 - EP KR US); A61K 47/12 (2013.01 - KR); A61K 47/183 (2013.01 - EP KR US); A61P 17/00 (2018.01 - EP KR); A61P 31/10 (2018.01 - EP KR); A61P 35/00 (2018.01 - EP KR); A61K 47/12 (2013.01 - EP US)
Citation (search report)
- [A] US 6042845 A 20000328 - SUN YING [US], et al
- [A] VARSHA BHATT: "Development of an optimal formulation for efinaconazole a novel antifungal agent for the treatment of onychomycosis by topical application", JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, vol. 68, no. 4, 2 April 2013 (2013-04-02), XP055357687
- See also references of WO 2015051183A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
US 2015099785 A1 20150409; US 9662394 B2 20170530; AU 2014329421 A1 20160407; AU 2014329421 B2 20180802; CA 2924748 A1 20150409; CA 2924748 C 20190903; CN 105683184 A 20160615; CN 105683184 B 20190510; CN 110433291 A 20191112; CN 110433291 B 20230428; EP 3052487 A1 20160810; EP 3052487 A4 20170503; EP 3052487 B1 20180905; IL 244850 A0 20160531; IL 244850 B 20200430; JP 2016532722 A 20161020; JP 2019108388 A 20190704; JP 2020169207 A 20201015; JP 6516759 B2 20190522; JP 6774518 B2 20201028; KR 102320051 B1 20211029; KR 20160068812 A 20160615; MX 2016004168 A 20160908; MX 363386 B 20190320; MY 179756 A 20201112; PH 12016500586 A1 20160523; PH 12016500586 B1 20160523; SG 11201602596U A 20160428; US 10342875 B2 20190709; US 10864274 B2 20201215; US 12076404 B2 20240903; US 2017326240 A1 20171116; US 2019358329 A1 20191128; US 2021205457 A1 20210708; WO 2015051183 A1 20150409
DOCDB simple family (application)
US 201414505379 A 20141002; AU 2014329421 A 20141002; CA 2924748 A 20141002; CN 201480054496 A 20141002; CN 201910299158 A 20141002; EP 14851133 A 20141002; IL 24485016 A 20160331; JP 2016546886 A 20141002; JP 2019041262 A 20190307; JP 2020118180 A 20200709; KR 20167010978 A 20141002; MX 2016004168 A 20141002; MY PI2016000570 A 20141002; PH 12016500586 A 20160331; SG 11201602596U A 20141002; US 2014058911 W 20141002; US 201715607594 A 20170529; US 201916435310 A 20190607; US 202017119780 A 20201211